These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18370222

  • 1. DNA vaccination for prostate cancer.
    Roos AK, King A, Pisa P.
    Methods Mol Biol; 2008; 423():463-72. PubMed ID: 18370222
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P.
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [Abstract] [Full Text] [Related]

  • 3. Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants.
    Kim JJ, Yang JS, Dang K, Manson KH, Weiner DB.
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):882s-889s. PubMed ID: 11300487
    [Abstract] [Full Text] [Related]

  • 4. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
    Roos AK, Pavlenko M, Charo J, Egevad L, Pisa P.
    Prostate; 2005 Feb 15; 62(3):217-23. PubMed ID: 15389792
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 15; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 9. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 10. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K, Roos AK, Pavlenko M, Leder C, Wehrum D, Guevara-Patiño J, Andersen RS, Pisa P.
    Vaccine; 2009 Mar 04; 27(10):1557-65. PubMed ID: 19171173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
    Lubaroff DM, Karan D.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):268-74. PubMed ID: 19166887
    [Abstract] [Full Text] [Related]

  • 13. Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen.
    Kim JJ, Yang JS, Nottingham LK, Tang W, Dang K, Manson KH, Wyand MS, Wilson DM, Weiner DB.
    Oncogene; 2001 Jul 27; 20(33):4497-506. PubMed ID: 11494145
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HER2/neu DNA vaccination for breast tumors.
    Smorlesi A, Papalini F, Pierpaoli S, Provinciali M.
    Methods Mol Biol; 2008 Jul 27; 423():473-85. PubMed ID: 18370223
    [Abstract] [Full Text] [Related]

  • 16. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer.
    Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM.
    Cancer Res; 2007 Feb 01; 67(3):1344-51. PubMed ID: 17283172
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M, Leder C, Pisa P.
    Expert Rev Vaccines; 2005 Jun 01; 4(3):315-27. PubMed ID: 16026247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.